Volition logo logo
q3 2024 featured

VolitionRx Limited Announces Third Quarter 2024 Financial Re…

Press Releases
q3 2024 featured

VolitionRx Limited Schedules Third Quarter 2024 Earnings Con…

Press Releases
Tim Still news release

Volition Appoints Timothy I. Still as Chairman

Press Releases
esicm report release

Multiple studies show Nu.Q® NETs test could predict sepsis p…

Press Releases
esicm 2024 featured 1

Volition to share new ‘NETs in sepsis management’ data insig…

Press Releases
esicm 2024 thumbnail

Volition hosts NETs in sepsis management symposium at ESICM …

Press Releases

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases

ethel rubin featured

Volition Appoints Dr. Ethel Rubin as an Independent Director

Press Releases
KOL Thumbnail

Volition Hosts KOL Roundtable on Sepsis

Press Releases
Q2 2024 earnings announcement

VolitionRx Limited Announces Second Quarter 2024 Financial R…

Press Releases
volition featured image

VolitionRx Announces Pricing of up to $21.5 Million Register…

Press Releases
Q2 2024 earnings announcement

VolitionRx Limited Schedules Second Quarter 2024 Earnings Co…

Press Releases
pharamaventures

Volition appoints PharmaVentures for Capture PCR™ and oncolo…

Press Releases
Volition_231115_0136

VolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annu…

Press Releases
jefferies

VolitionRx Limited to Present at Jefferies Global Healthcare…

Press Releases
120101_VNRX534

VolitionRx Limited Announces First Quarter 2024 Financial Re…

Press Releases
120101_VNRX534

VolitionRx Limited Schedules First Quarter 2024 Earnings Con…

Press Releases
Antech's Element i+ analyser

Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe …

Press Releases
120101_VNRX524

VolitionRx Limited Announces Full Fiscal Year 2023 Financial…

Press Releases
120101_VNRX524

VolitionRx Limited Schedules Fourth Quarter and Full Year 20…

Press Releases
fuji release image

Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Te…

Press Releases
Dr Andrew Retter

Volition appoints Dr Andrew Retter as Chief Medical Officer

Press Releases
Volition Belgium Day 1 - June 20220594_High_res

Volition to Share Nu.Q® NETs Strategy Update at Upcoming Web…

Press Releases
Volition 230619

Volition Issues Business Review 2023

Press Releases
Untitled design (2)

Volition Presents at the 5th Annual Congress of the Internat…

Press Releases
120101_VNRX540

VolitionRx Limited Announces Third Quarter 2023 Financial Re…

Press Releases
120101_VNRX540

VolitionRx Limited Schedules Third Quarter 2023 Earnings Con…

Press Releases
eugene-chystiakov-S-jos2upivU-unsplash

Volition and VPG Launch Nu.Q® Vet Cancer Test in UK & I…

Press Releases
Untitled design (3)

Volition Presents Breakthrough Liquid Biopsy Blood Test Meth…

Press Releases
Volition Belgium Day 1 - June 20220594_High_res

Measuring Nucleosomes Using Nu.Q® NETs is a Promising Biomar…

Press Releases
post 2

US Ambassador Adler visits Belgian Volition

Press Releases
Untitled design (3)

Volition Presents Three Cancer Detection Abstracts at ESMO 2…

Press Releases
Volition NETs KOL event Sept 2023

Volition Publishes Key Opinion Leader Roundtable Report on N…

Press Releases
Samples Overhead A_High res

Volition to Reveal New Cancer Detection Method Insights at U…

Press Releases
Volition Belgium Day 1 - June 20220594_High_res

Volition Hosts Key Opinion Leader Roundtable on Sepsis Manag…

Press Releases
120101_VNRX540

VolitionRx Limited Announces Second Quarter 2023 Financial R…

Press Releases
120101_VNRX540

VolitionRx Limited Schedules Second Quarter 2023 Earnings Co…

Press Releases
120101_VNRX540

VolitionRx Limited Announces Exercise of Over-Allotment Opti…

Press Releases
120101_VNRX540

VolitionRx Limited Announces Closing of $16.5 Million Underw…

Press Releases
Volition Belgium, October 2023.

VolitionRx Limited Announces Pricing of $16.5 Million Underw…

Press Releases
volition-sepsis-6

VolitionRx Limited Announces Proposed Underwritten Public Of…

Press Releases
Untitled design (1)

VolitionRx Secures Approximately $5.5 Million in Belgium Reg…

Press Releases
volition-pet-owners-6

Volition Study shows Nucleosome Concentrations are a useful …

Press Releases
volition-capture-3

VolitionRx Limited Announces First Quarter 2023 Financial Re…

Press Releases
120101_VNRX519

VolitionRx Limited Schedules First Quarter 2023 Earnings Con…

Press Releases
120101_VNRX519

VolitionRx Limited to Host Capital Markets Day at the NYSE o…

Press Releases
120101_VNRX519

VolitionRx Limited Announces Full Fiscal Year 2022 Financial…

Press Releases
120101_VNRX540

VolitionRx Limited Schedules Full Year 2022 Earnings Confere…

Press Releases
volition-discover-3

VolitionRx Limited Announces Closing of $8.7 Million Underwr…

Press Releases
volition-veterinarians-2

VolitionRx Limited Announces Pricing of $7.525 Million Under…

Press Releases
volition-nets-1

VolitionRx Limited Announces Proposed Underwritten Public Of…

Press Releases
volition-pet-owners-4

Volition’s Nu.Q® Vet Cancer Test Now Available for Pre…

Press Releases
volition-pet-owners-9

Volition to Take Part in Nu.Q® Vet Commercial Strategy Webin…

Press Releases
Girl playing with her beagle dog in yard.

Volition Announces Expansion of Availability of the Nu.Q® Ve…

Press Releases
Volition Belgium Day 1 - June 20220650_High_res

Volition Issues Business Review 2022

Press Releases
120101_CBPRESS_4

VolitionRx Limited Announces Third Quarter 2022 Financial Re…

Press Releases
volition-pet-owners-8

Volition Announces Clinical Research Study with Oncovet

Press Releases
volition-nets-6

Volition to Participate in a Lung Cancer Screening Study in …

Press Releases
120101_VNRX519

VolitionRx Limited Schedules Third Quarter 2022 Earnings Con…

Press Releases
volition-veterinarians-3

Volition Announces the Launch of the Nu.Q® Vet Cancer Screen…

Press Releases
Larger beagle image

Volition Signs Global Supply Agreement for Nu.Q® Vet Cancer …

Press Releases
Volition 230619

Volition Appoints Mickie Henshall as an Independent Director

Press Releases
120101_VNRX519

VolitionRx Limited Announces Second Quarter 2022 Financial R…

Press Releases
Netosis illustration

Volition Announces U.S. Clinical Study for NETs

Press Releases
120101_VNRX540

VolitionRx Limited Schedules Second Quarter 2022 Earnings Co…

Press Releases
volition-veterinarians-2

Volition Appoints DXOCRO to Spearhead U.S. FDA Strategy

Press Releases
Untitled design

VolitionRx Awarded $1.5 Million in Non-Dilutive Funding

Press Releases
1266_High_res

VolitionRx Limited Announces Closing of $6.9 Million Underwr…

Press Releases
volition-veterinarians-4

VolitionRx Limited Announces Pricing of $6 Million Underwrit…

Press Releases
Volition Belgium Day 1 - June 20220594_High_res

New NETs Data Presented at International Society on Thrombos…

Press Releases
Sharon_Ballesteros 2022

Volition appoints Sharon Ballesteros as U.S. Head of Quality…

Press Releases
Volition Belgium Day 1 - June 20220668_High_res

Volition Achieves CE Mark for Nu.Q® NETs Test

Press Releases
120101_VNRX540

VolitionRx Limited Announces First Quarter 2022 Financial Re…

Press Releases
sebastian-coman-travel-JgKfmp9uq9w-unsplash

Volition launches its Nu.Q®Vet Cancer Test in Asia through i…

Press Releases
120101_VNRX540

VolitionRx Limited Announces Full Fiscal Year 2021 Financial…

Press Releases
Hero Image

Volition Signs Exclusive $28 million License and Supply Agre…

Press Releases
120101_VNRX540

VolitionRx Limited Schedules Full Fiscal Year 2021 Earnings …

Press Releases
Untitled design (1)

Volition presents study data at ASCO GI 2022 on circulating …

Press Releases